E2 ModerateModerate confidencePEM ?Cross-SectionalPeer-reviewedMachine draft
Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union.
Strand, Elin B, Nacul, Luis, Mengshoel, Anne Marit et al. · PloS one · 2019 · DOI
Quick Summary
This study looked at how ME/CFS is diagnosed and treated across 17 European countries by surveying doctors and health organizations. The researchers found that different countries use different diagnostic tests and treatment approaches, with no standard way of doing things across Europe. The study shows that there is confusion and inconsistency in how ME/CFS patients are evaluated and cared for, which suggests that Europe needs to agree on common guidelines.
Why It Matters
This research reveals significant gaps in ME/CFS care standardization across Europe, which directly affects patients by creating uncertainty about whether they receive evidence-based, consistent care. The findings highlight an urgent need for harmonized diagnostic and treatment guidelines, which could improve diagnosis rates, reduce diagnostic delays, and ensure more equitable access to appropriate management strategies. This study provides evidence supporting calls for coordinated European healthcare policy on ME/CFS.
Observed Findings
- Only 5 of 17 surveyed countries reported having national diagnostic guidelines for ME/CFS, and only 5 had guidelines for clinical management approaches.
- The Fukuda criteria were the most frequently recommended diagnostic standard, followed by Canadian Consensus, International Consensus, and Oxford criteria, often applied inconsistently within individual countries.
- Pain medication and antidepressants were the most commonly recommended pharmacological treatments for symptom relief across surveyed countries.
- Cognitive Behavioral Therapy and Graded Exercise Therapy were frequently recommended as disease management strategies despite ongoing debate about their appropriateness for ME/CFS.
- Wide variation existed in the questionnaires and diagnostic tests used for symptom assessment and investigation across European countries.
Inferred Conclusions
- The lack of consensus on diagnostic criteria and treatment strategies across European countries represents a significant gap in ME/CFS care standardization that may lead to inequitable diagnosis and management.
- Development of coordinated European regulations, guidance, and standards is necessary to harmonize ME/CFS diagnostic criteria and treatment recommendations.
- The variation in current practice reflects the complexity of ME/CFS and the absence of robust, universally accepted evidence for specific approaches, necessitating further research.
- National guideline development and international harmonization efforts are urgently needed to improve consistency and quality of care for ME/CFS patients across Europe.
What This Study Does Not Prove
This survey does not evaluate the effectiveness or superiority of any particular diagnostic criteria or treatment approach—it only describes what is currently being used. The study does not establish whether countries with guidelines have better patient outcomes than those without them. It also does not prove that harmonization alone would improve patient care; implementation quality and resources would also be critical factors.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Method Flag:Weak Case DefinitionNo ControlsExploratory Only